Day One Biopharmaceuticals (DAWN) Earnings Date, Estimates & Call Transcripts $9.06 -0.38 (-4.03%) Closing price 04:00 PM EasternExtended Trading$9.21 +0.15 (+1.66%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5After Market ClosesEstimatedActual EPS (Feb. 25) -$0.69 Missed By -$0.34 Consensus EPS (Feb. 25) -$0.35 Day One Biopharmaceuticals released Q4 2024 earnings on February 25, 2025, reporting an EPS of -$0.69, which missed the consensus estimate of -$0.35 by $0.34. Quarterly revenue was reported to be $29.21 million, above analysts' expectations of $27.11 million. With a trailing EPS of -$1.03, Day One Biopharmaceuticals' earnings are expected to decrease next year, from ($0.72) to ($0.97) per share. Conference CallConference Call TranscriptDAWN Upcoming EarningsDay One Biopharmaceuticals' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get Day One Biopharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Day One Biopharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDAWN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DAWN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Day One Biopharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.43-$0.28-$0.36Q2 20252-$0.39-$0.26-$0.33Q3 20252-$0.35-$0.23-$0.29Q4 20252-$0.26-$0.18-$0.22FY 20258($1.43)($0.95)($1.19) Day One Biopharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------2/25/2025Q4 2024-$0.35-$0.69 -$0.34-$0.69$27.11M$29.21M10/30/2024Q3 2024-$0.20$0.38+$0.58$0.38$15.05M$93.76M7/30/2024Q2 2024-$0.75-$0.05+$0.70-$0.05$0.90M$8.19M5/6/2024Q1 2024-$0.67-$0.72 -$0.05-$0.72--2/26/2024Q4 2023-$0.57-$0.64 -$0.07-$0.64--11/6/2023Q3 2023-$0.60-$0.54+$0.06-$0.54--8/7/2023Q2 2023-$0.60-$0.61 -$0.01-$0.61--5/1/2023Q1 2023-$0.59-$0.59--$0.59--3/6/2023Q4 2022-$0.57-$0.56+$0.01-$0.56-- Day One Biopharmaceuticals Earnings - Frequently Asked Questions When is Day One Biopharmaceuticals's earnings date? Day One Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on DAWN's earnings history. Did Day One Biopharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Day One Biopharmaceuticals (NASDAQ:DAWN) missed the analysts' consensus estimate of ($0.35) by $0.34 with a reported earnings per share (EPS) of ($0.69). Learn more on analysts' earnings estimate vs. DAWN's actual earnings. How can I listen to Day One Biopharmaceuticals's earnings conference call? The conference call for Day One Biopharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Day One Biopharmaceuticals's conference call transcript? The conference call transcript for Day One Biopharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded annual revenue of $101.95 million. How much profit does Day One Biopharmaceuticals generate each year? Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded net income of -$188.92 million. DAWN has generated -$1.03 earnings per share over the last four quarters. What is Day One Biopharmaceuticals's EPS forecast for next year? Day One Biopharmaceuticals's earnings are expected to decrease from ($0.72) per share to ($0.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies TGTX Earnings Date SWTX Earnings Date OGN Earnings Date RARE Earnings Date PTCT Earnings Date ADMA Earnings Date RNA Earnings Date ZLAB Earnings Date BHVN Earnings Date ALVO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NASDAQ:DAWN) was last updated on 2/28/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DAWN Stock Alerts